Jagsonpal Pharmaceuticals (BOM:507789) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:507789 Jagsonpal Pharmaceuticals Ltd BOM:507789
71 GF Score
Price ₹230.00
GF Value ₹205.39
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jagsonpal Pharmaceuticals Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:507789 vs ZTS, UTHR: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jagsonpal Pharmaceuticals's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jagsonpal Pharmaceuticals Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jagsonpal Pharmaceuticals's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Jagsonpal Pharmaceuticals's Short Percentage of Float falls into.


BOM:507789
71GF Score
Jagsonpal Pharmaceuticals Ltd BOM:507789
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jagsonpal Pharmaceuticals (BOM:507789) Overvalued in 2026?

Based on GuruFocus' analysis, Jagsonpal Pharmaceuticals stock appears to be overvalued. The current stock price of ₹230.00 is trading 12% above its estimated GF Value™ of ₹205.39. GuruFocus considers Jagsonpal Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for BOM:507789:

  • Short Percentage of Float:
  • GF Value™: ₹205.39 vs. price of ₹230.00 (12% above fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the BOM:507789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jagsonpal Pharmaceuticals Business Description

Other Exchanges JAGSNPHARM:India
Address 3rd Floor, Phase - IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Doxypal DR, and others.
71GF Score

Get the complete analysis for BOM:507789

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹230.00
Price
₹205.39
GF Value